JHJosé Huilca

José Huilca

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


José Huilca has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Validity of the two different scoring methods of the Clinical Dementia Rating scale in staging and detection of cognitive impairment in the Peruvian population

    by Junior Senador, Rosa Montesinos, Belén Custodio, Jose Huilca, Katherine Agüero, Graciet Verastegui, Pamela Bartolo, Milagros Nuñez‐Huanca, María Fe Albujar Pereira, Nilton Custodio

    INTRODUCTION: In Peru, the Global Deterioration Scale is the only available tool for assessing dementia severity. The Spanish translation and cultural adaptation of the Clinical Dementia Rating (CDR) is used locally but requires formal psychometric validation in the Peruvian sociocultural context. METHODS: A total of 1,600 older adults: 902 controls, 271 mild cognitive impairment (MCI), and 427 Alzheimer's disease patients (AD) were assessed to validate two CDR scoring methods: CDR Global Score (CDR‐GS) and CDR Sum of Boxes Score (CDR‐SB). Discriminative validity, inter‐item reliability, and concurrent validity were evaluated using MMSE, RUDAS, PFAQ, and Uniform Data Set (UDS) v3 Neuropsychological Battery. RESULTS: CDR demonstrated high reliability and validity among normal cognition, mild cognitive impairment, and AD. For AD screening, CDR‐SB showed 98.2% sensitivity and 99.6% specificity, while CDR‐GS demonstrated 99.8% sensitivity and 100% specificity. DISCUSSION: The Peruvian CDR version exhibited good psychometric properties comparable to those reported in Latin American CDR validation studies.

  • Open Access

    Cognitive impairment on the Alzheimer's Disease Centers' Uniform Data Set Version 3 Neuropsychological Test Battery in a Peruvian population with progressive supranuclear palsy

    by Nilton Custodio, Rosa Montesinos, Belén Custodio, Marco Malaga, Alfonso Uribe, Milagros Nuñez, Pamela Bartolo, Zadith Yauri, Katherine Agüero, Graciet Verastegui, et al.

    Research on the cognitive profile in progressive supranuclear palsy (PSP) has been scarce in Latin America. To outline the demographic, clinical, and cognitive profile of Peruvian PSP patients living in Lima, Peru. We sought to determine the relationship between first clinical symptoms and specific cognitive abilities. A cross-sectional study of 34 PSP subjects. We used the Uniform Data Set Version 3 Neuropsychological Battery (UDS3-NB), which possesses normative data for the Peruvian population, to assess global and specific cognitive functions. We also performed correlation analyses to determine the relationship between presenting clinical symptoms (parkinsonism, postural instability, and cognitive impairment) and cognitive functioning. The mean age was 68 years, and mean schooling was 12.1 years in this cohort. The most common initial clinical symptom was parkinsonism (55.9%), followed by postural instability (23.5%) and dementia (20.6%). Our cohort showed poor performance on global cognition, with selective impairment of processing speed, executive function, and episodic memory. Attentional and visuospatial skills were mildly affected, with partial preservation of naming. There was no significant relationship between the initial clinical symptoms and global cognition, except for a slight correlation between parkinsonism and visuospatial function (r = 0.18; p < 0.05). We found that PSP patients in Peru had extensive impairment in executive function, processing speed, and episodic memory, with relatively preserved naming, consistent with other international cohorts. We did not find a correlation between initial clinical signs and cognitive profile, suggesting that an interdisciplinary approach is needed to evaluate patients with suspicion for PSP. Longitudinal studies are needed to more clearly define the progression of neuropsychiatric symptoms in PSP patients.

  • Perceptions of Peruvian neurologists toward the implementation of anti-amyloid drugs for early Alzheimer's disease in the departments of neurology

    by Belen Custodio, Rosa Montesinos, William Bayona, Mayra Janett Rojas Benites, Isabel Camargo, Milagros Ibañez, José Huilca, Adrián Noriega de la Colina, Jordi A. Matias-Guiu, Nilton Custodio

    Background: Alzheimer's disease (AD) is a neurodegenerative disease affecting millions globally, with particular severity in low- and middle-income countries due to barriers in timely diagnosis and treatment. To date, two monoclonal anti-amyloids have shown positive results in phase III clinical trials. However, their administration is complex, requiring specialized infrastructure, highly trained professionals, and regular follow-ups, posing major challenges for healthcare systems. Objective: This study explores Peruvian neurologists’ perceptions of changes needed to implement monoclonal antibodies in line with clinical guidelines. Methods: A cross-sectional study was conducted in Peru using the key informant (KI) methodology. KI were neurologists from multiple regions across the country. A comprehensive list of tertiary-level hospitals (public healthcare system, social security, and police and armed forces) was compiled, and at least one neurologist from each institution was contacted. The instrument used was adapted from a study conducted in Spain, which included questions focusing on changes in diagnosis, patient care, diagnostic and therapeutic techniques, public and family impact, neurology resources, and dementia research. Data analysis was employed using Stata18, using descriptive statistics and frequency distributions. Results: Twenty-eight neurologists completed the survey. There was consensus on the significant impact monoclonal antibodies would have on neurology services. Over 85% agreed that more neurologists and nurses would be needed. Additionally, 93% supported using brief diagnostic scales in primary care and increasing follow-up visit frequency. Conclusions: The introduction of monoclonal antibodies for AD in Peru requires modifications to healthcare institutions, highlighting the urgent need for strategic healthcare planning.

  • Open Access

    Improving participants’ recruitment in dementia-related studies on social media through colloquial language in Lima, Peru

    by Belén Custodio, Maria Mora-Pinzon, Rosa Montesinos, Maria Eugenia Godoy, José Carlos Huilca, Katherine Agüero, Nilton Custodio

    Recruitment for dementia research remains a persistent challenge, particularly when trying to reach underrepresented groups such as Latin Americans with traditional enrollment strategies. Objective: In this retrospective case study, we investigate two communication approaches used on social media to recruit participants for a dementia research study in Lima, Peru. Methods: Initially, recruitment materials featured medical terminology, which was later replaced by colloquial language to make the content more accessible. Results: According to the results, using simpler and more relatable language led to an increase in participants’ contacts and enrollments. This suggests that culturally tailored communication strategies may be more effective in reaching diverse populations. Conclusion: The findings highlight the importance of adapting research recruitment efforts to the target community’s cultural and linguistic context to improve engagement in dementia studies.